Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2013-07-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Markers of Response to Treatment in Resistant Depression
NCT02774980
Inflammatory Markers and Resistant Depression
NCT02847533
Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder
NCT02286024
Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression
NCT03690856
Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion
NCT02026622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A correlation analysis will be performed with rhythmic parameters and the response to the antidepressant treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
responder
responder to antidepressant treatment
rhythmic parameter recording
the following rhythmic parameters are recording during 48 hours: temperature, heart rate and actimetry
psychiatric assessment
different psychometric scales are filled in: Montgomery and Asberg depression rating scale (MADRS), Quick inventory depression scale (QIDS-C16) and Beck depression inventory (BDI)
non responder
non responder to antidepressant treatment
rhythmic parameter recording
the following rhythmic parameters are recording during 48 hours: temperature, heart rate and actimetry
psychiatric assessment
different psychometric scales are filled in: Montgomery and Asberg depression rating scale (MADRS), Quick inventory depression scale (QIDS-C16) and Beck depression inventory (BDI)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rhythmic parameter recording
the following rhythmic parameters are recording during 48 hours: temperature, heart rate and actimetry
psychiatric assessment
different psychometric scales are filled in: Montgomery and Asberg depression rating scale (MADRS), Quick inventory depression scale (QIDS-C16) and Beck depression inventory (BDI)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MADRS score \> 25
Exclusion Criteria
* current treatment with thymoregulating agent
* clozapine treatment
* heart disease that could alter heart rate characteristics
* disease associated with fever
* shift work within 3 months before inclusion
* transmeridian travel in the preceding month
* guardianship
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
University Hospital, Strasbourg, France
OTHER
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel Haffen, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Besancon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Besancon
Besançon, Doubs, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2011/120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.